A Phase 3 Trial of Inebilizumab in Generalized Myasthenia GravisNEJM 392:2309-2320, Nowak,R.J.,et al, 2025
Alemtuzumab vs. Interferon Beta-1a in Early Multiple SclerosisNEJM 359:1786-1801,1838, The CAMMS223 Trial Investigators, 2008